136 related articles for article (PubMed ID: 38060005)
21. Diabetic ketoacidosis (DKA) in type 1 diabetes mellitus (T1DM) temporally related to COVID-19 vaccination.
Ganakumar V; Jethwani P; Roy A; Shukla R; Mittal M; Garg MK
Diabetes Metab Syndr; 2022 Jan; 16(1):102371. PubMed ID: 34954484
[TBL] [Abstract][Full Text] [Related]
22. COVID-19 vaccination during pregnancy: coverage and safety.
Blakeway H; Prasad S; Kalafat E; Heath PT; Ladhani SN; Le Doare K; Magee LA; O'Brien P; Rezvani A; von Dadelszen P; Khalil A
Am J Obstet Gynecol; 2022 Feb; 226(2):236.e1-236.e14. PubMed ID: 34389291
[TBL] [Abstract][Full Text] [Related]
23. Higher rate of COVID-19 mortality in patients with type 1 than type 2 diabetes: a nationwide study.
Demirci I; Haymana C; Tasci I; Satman I; Atmaca A; Sahin M; Ata N; Unluturk U; Cakal E; Dagdelen S; Sahin I; Celik O; Ertugrul D; Demir T; Emral R; Caglayan M; Salman S; Birinci S; Sonmez A
Endokrynol Pol; 2022; 73(1):87-95. PubMed ID: 35119089
[TBL] [Abstract][Full Text] [Related]
24. Breakthrough SARS-CoV-2 infections and prediction of moderate-to-severe outcomes during rituximab therapy in patients with rheumatic and musculoskeletal diseases in the UK: a single-centre cohort study.
Md Yusof MY; Arnold J; Saleem B; Vandevelde C; Dass S; Savic S; Vital EM; Emery P
Lancet Rheumatol; 2023 Feb; 5(2):e88-e98. PubMed ID: 36712951
[TBL] [Abstract][Full Text] [Related]
25. Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD study.
Naveen R; Nikiphorou E; Joshi M; Sen P; Lindblom J; Agarwal V; Lilleker JB; Tan AL; Salim B; Ziade N; Velikova T; Gracia-Ramos AE; Kuwana M; Day J; Makol A; Distler O; Chinoy H; Traboco LS; Wibowo SAK; Tehozol EAZ; Serrano JR; García-De La Torre I; ; Aggarwal R; Gupta L; Agarwal V; Parodis I
Rheumatology (Oxford); 2023 Jul; 62(7):2453-2463. PubMed ID: 36413073
[TBL] [Abstract][Full Text] [Related]
26. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
27. COVID-19 vaccine coverage, safety, and perceptions among patients with diabetes mellitus in China: a cross-sectional study.
Li H; Ping F; Li X; Wang Z; Xiao J; Jiang H; Xue Y; Quan J; Yao H; Zheng X; Chen Y; Li Y; Yu X; Xu L; Feng X; Wang S; Li Y; Xiao X
Front Endocrinol (Lausanne); 2023; 14():1172089. PubMed ID: 37334292
[TBL] [Abstract][Full Text] [Related]
28. Autoimmune conditions following mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccination: A descriptive cohort study among 1.1 million vaccinated people in Hong Kong.
Li X; Gao L; Tong X; Chan VKY; Chui CSL; Lai FTT; Wong CKH; Wan EYF; Chan EWY; Lau KK; Lau CS; Wong ICK
J Autoimmun; 2022 Jun; 130():102830. PubMed ID: 35461018
[TBL] [Abstract][Full Text] [Related]
29. Characteristics and outcomes of SARS-CoV-2 breakthrough infections among double-vaccinated and triple-vaccinated patients with inflammatory rheumatic diseases.
Hasseli R; Richter JG; Hoyer BF; Lorenz HM; Pfeil A; Regierer AC; Schmeiser T; Strangfeld A; Voll RE; Krause A; Reckert S; Gräßler A; Saar P; Kapelle A; Backhaus M; Blank N; Henes J; Osiek S; Knothe A; Hoese G; Brandt-Jürgens J; Maltzahn A; Specker C; Müller-Ladner U; Schulze-Koops H; ;
RMD Open; 2023 Apr; 9(2):. PubMed ID: 37068915
[TBL] [Abstract][Full Text] [Related]
30. Incidence of diabetes following COVID-19 vaccination and SARS-CoV-2 infection in Hong Kong: A population-based cohort study.
Xiong X; Lui DTW; Chung MSH; Au ICH; Lai FTT; Wan EYF; Chui CSL; Li X; Cheng FWT; Cheung CL; Chan EWY; Lee CH; Woo YC; Tan KCB; Wong CKH; Wong ICK
PLoS Med; 2023 Jul; 20(7):e1004274. PubMed ID: 37486927
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness of delayed second dose of AZD1222 vaccine in patients with autoimmune rheumatic disease.
Mehta P; Paul A; Ahmed S; Cherian S; Panthak A; Benny J; Shenoy P
Clin Rheumatol; 2022 Nov; 41(11):3537-3542. PubMed ID: 35760938
[TBL] [Abstract][Full Text] [Related]
32. Pneumonia Frequency and Severity in Patients With Symptomatic COVID-19: Impact of mRNA and Adenovirus Vector Vaccines.
Vicini S; Bellini D; Iannarelli A; Rengo M; Pelle G; Ruggiero S; Fusco M; Ambrogi C; Carbone I
AJR Am J Roentgenol; 2022 Nov; 219(5):752-761. PubMed ID: 35642761
[No Abstract] [Full Text] [Related]
33. Breakthrough covid 19 infections after 2 doses of covid 19 vaccination and comparing severity between hospitalized and non hospitalized in tertiary care hospital.
S M; Hr C
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443499
[TBL] [Abstract][Full Text] [Related]
34. Risk of breakthrough SARS-CoV-2 infection and clinical outcomes among vaccinated patients with type 2 diabetes.
Bea S; Choi A; Kim JH; Cho YM; Choi WS; Jung J; Shin JY
Diabetes Obes Metab; 2023 Sep; 25(9):2734-2742. PubMed ID: 37312652
[TBL] [Abstract][Full Text] [Related]
35. BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel.
Brosh-Nissimov T; Orenbuch-Harroch E; Chowers M; Elbaz M; Nesher L; Stein M; Maor Y; Cohen R; Hussein K; Weinberger M; Zimhony O; Chazan B; Najjar R; Zayyad H; Rahav G; Wiener-Well Y
Clin Microbiol Infect; 2021 Nov; 27(11):1652-1657. PubMed ID: 34245907
[TBL] [Abstract][Full Text] [Related]
36. Late-Onset T1DM and Older Age Predict Risk of Additional Autoimmune Disease.
Hughes JW; Bao YK; Salam M; Joshi P; Kilpatrick CR; Juneja K; Nieves D; Bouhairie V; Jordan OJ; Blustein EC; Tobin GS; McGill JB
Diabetes Care; 2019 Jan; 42(1):32-38. PubMed ID: 30361208
[TBL] [Abstract][Full Text] [Related]
37. Imaging and Clinical Features of COVID-19 Breakthrough Infections: A Multicenter Study.
Lee JE; Hwang M; Kim YH; Chung MJ; Sim BH; Chae KJ; Yoo JY; Jeong YJ
Radiology; 2022 Jun; 303(3):682-692. PubMed ID: 35103535
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of β-cell antibodies and associated autoimmune diseases in children and adolescents with type 1 diabetes (T1DM) versus type 2 diabetes (T2DM) in Qatar.
Alyafei F; Soliman A; Alkhalaf F; Sabt A; De Sanctis V; Elsayed N; Waseef R
Acta Biomed; 2018 May; 89(S5):32-39. PubMed ID: 30049930
[TBL] [Abstract][Full Text] [Related]
39. Postvaccination antibody titres predict protection against COVID-19 in patients with autoimmune diseases: survival analysis in a prospective cohort.
Ahmed S; Mehta P; Paul A; Anu S; Cherian S; Shenoy V; Nalianda KK; Joseph S; Poulose A; Shenoy P
Ann Rheum Dis; 2022 Jun; 81(6):868-874. PubMed ID: 35135831
[TBL] [Abstract][Full Text] [Related]
40. Timing of last COVID-19 vaccine dose and SARS-CoV-2 breakthrough infections in fully (boosted) vaccinated healthcare personnel.
Maltezou HC; Gamaletsou MN; Giannouchos TV; Koukou DM; Karapanou A; Sourri F; Syrimi N; Lemonakis N; Peskelidou E; Papanastasiou K; Souliotis K; Lourida A; Panagopoulos P; Hatzigeorgiou D; Sipsas NV
J Hosp Infect; 2023 Feb; 132():46-51. PubMed ID: 36473554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
